506 related articles for article (PubMed ID: 16787796)
1. Ibutilide to expedite ED therapy for recent-onset atrial fibrillation flutter.
Mountantonakis SE; Moutzouris DA; Tiu RV; Papaioannou GN; McPherson CA
Am J Emerg Med; 2006 Jul; 24(4):407-12. PubMed ID: 16787796
[TBL] [Abstract][Full Text] [Related]
2. [Immediate cardioversion of atrial fibrillation and atrial flutter lasting less than 90 days by ibutilide versus propafenone: a multicenter study].
Zhang HC; Guo JH; Fang Q; Zheng YA; Sun YM; Zhu WQ; Wan Z; Guo JX; Ge JB; Han SM
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(12):798-801. PubMed ID: 15949393
[TBL] [Abstract][Full Text] [Related]
3. Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.
Chiladakis JA; Kalogeropoulos A; Patsouras N; Manolis AS
J Am Coll Cardiol; 2004 Aug; 44(4):859-63. PubMed ID: 15312872
[TBL] [Abstract][Full Text] [Related]
4. Conversion efficacy of intravenous ibutilide compared with intravenous amiodarone in patients with recent-onset atrial fibrillation and atrial flutter.
Kafkas NV; Patsilinakos SP; Mertzanos GA; Papageorgiou KI; Chaveles JI; Dagadaki OK; Kelesidis KM
Int J Cardiol; 2007 Jun; 118(3):321-5. PubMed ID: 17049640
[TBL] [Abstract][Full Text] [Related]
5. Ibutilide for cardioversion of atrial flutter: efficacy of a single dose in recent-onset arrhythmias.
Andò G; Di Rosa S; Rizzo F; Carerj S; Bramanti O; Giannetto M; Arrigo F
Minerva Cardioangiol; 2004 Feb; 52(1):37-42. PubMed ID: 14765036
[TBL] [Abstract][Full Text] [Related]
6. Ibutilide for treatment of atrial fibrillation in the emergency department.
Viktorsdottir O; Henriksdottir A; Arnar DO
Emerg Med J; 2006 Feb; 23(2):133-4. PubMed ID: 16439743
[TBL] [Abstract][Full Text] [Related]
7. Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agents.
Hongo RH; Themistoclakis S; Raviele A; Bonso A; Rossillo A; Glatter KA; Yang Y; Scheinman MM
J Am Coll Cardiol; 2004 Aug; 44(4):864-8. PubMed ID: 15312873
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of ibutilide in cardioversion of atrial flutter and fibrillation.
Nair M; George LK; Koshy SK
J Am Board Fam Med; 2011; 24(1):86-92. PubMed ID: 21209348
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of ibutilide for cardioversion of atrial flutter and fibrillation in patients receiving amiodarone or propafenone.
Fragakis N; Papadopoulos N; Papanastasiou S; Kozirakis M; Maligkos G; Tsaritsaniotis E; Katsaris G
Pacing Clin Electrophysiol; 2005 Sep; 28(9):954-61. PubMed ID: 16176535
[TBL] [Abstract][Full Text] [Related]
10. Ibutilide versus amiodarone in atrial fibrillation: a double-blinded, randomized study.
Bernard EO; Schmid ER; Schmidlin D; Scharf C; Candinas R; Germann R
Crit Care Med; 2003 Apr; 31(4):1031-4. PubMed ID: 12682468
[TBL] [Abstract][Full Text] [Related]
11. Ibutilide: an antiarrhythmic agent for the treatment of atrial fibrillation or flutter.
Howard PA
Ann Pharmacother; 1999 Jan; 33(1):38-47. PubMed ID: 9972384
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy and safety of ibutilide for conversion of atrial fibrillation/flutter].
Yu Z; Xiang M; Ma C; Zhang S; Yang Y
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2013 Mar; 42(2):212-6. PubMed ID: 23585009
[TBL] [Abstract][Full Text] [Related]
13. The cost-effectiveness of ibutilide versus electrical cardioversion in the conversion of atrial fibrillation and flutter to normal rhythm.
Zarkin GA; Bala MV; Calingaert B; VanderLugt JT
Am J Manag Care; 1997 Sep; 3(9):1387-94. PubMed ID: 10178487
[TBL] [Abstract][Full Text] [Related]
14. Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation: electrophysiological determinants of enhanced conversion efficacy.
Stambler BS; Wood MA; Ellenbogen KA
Circulation; 1997 Dec; 96(12):4298-306. PubMed ID: 9416896
[TBL] [Abstract][Full Text] [Related]
15. Ibutilide: a new class III antiarrhythmic agent.
Cropp JS; Antal EG; Talbert RL
Pharmacotherapy; 1997; 17(1):1-9. PubMed ID: 9017761
[TBL] [Abstract][Full Text] [Related]
16. Emergency department use of intravenous procainamide for patients with acute atrial fibrillation or flutter.
Stiell IG; Clement CM; Symington C; Perry JJ; Vaillancourt C; Wells GA
Acad Emerg Med; 2007 Dec; 14(12):1158-64. PubMed ID: 18045891
[TBL] [Abstract][Full Text] [Related]
17. Comparison of intravenous ibutilide vs. propafenone for rapid termination of recent onset atrial fibrillation.
Zhang N; Guo JH; Zhang HCh; Li XB; Zhang P; Xn Y
Int J Clin Pract; 2005 Dec; 59(12):1395-400. PubMed ID: 16351670
[TBL] [Abstract][Full Text] [Related]
18. Effect of high doses of magnesium on converting ibutilide to a safe and more effective agent.
Patsilinakos S; Christou A; Kafkas N; Nikolaou N; Antonatos D; Katsanos S; Spanodimos S; Babalis D
Am J Cardiol; 2010 Sep; 106(5):673-6. PubMed ID: 20723644
[TBL] [Abstract][Full Text] [Related]
19. Ibutilide in persistent atrial fibrillation refractory to conventional cardioversion methods.
Naegeli B; Straumann E; Bertel O
Int J Cardiol; 2005 Mar; 99(2):283-7. PubMed ID: 15749188
[TBL] [Abstract][Full Text] [Related]
20. Single dose of ibutilide for conversion of persistent atrial fibrillation after radiofrequency ablation.
Hou Y; Fang PH; Liu J; Li XF; Hu JQ; Zhang S
Chin Med J (Engl); 2011 Mar; 124(5):710-3. PubMed ID: 21518563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
